Implication for Clinical Trials From Longitudinal Tau-PET Accumulation Across Biological Alzheimer Disease Stages
{{output}}
Background and objectives: Tau-PET is increasingly used in Alzheimer disease (AD) clinical trials, both for participant selection based on disease stage and as an outcome measure. However, the longitudinal patterns of tau accumul... ...
